News|Articles|May 15, 2020
- Pharmaceutical Technology-05-15-2020
- Volume 2020 eBook
- Issue 2
Complications in Process Simulation Execution
Author(s)James P. Agalloco
Regulators have exaggerated expectations for simulated media fills.
Advertisement
Regulators have exaggerated expectations for simulated media fills.
This article reviews aspects of media fill execution in which regulatory expectations have created artificial compliance concerns and significant practical difficulties.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 10–14, 43
Citation
When referring to this article, please cite it as J. Agalloco, "Complications in Process Simulation Execution," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).
Articles in this issue
over 5 years ago
On Point: Biologics Drive Growth in Pre-Filled Syringesover 5 years ago
Instrumenting Single-Use Processesover 5 years ago
Considerations in Contamination Controlover 5 years ago
Best systems and equipment for contamination controlover 5 years ago
Building Data Quality In Generates Quality Data Outover 5 years ago
Detecting Contamination in Cell Therapiesover 5 years ago
Optimizing Viral Vector Manufacturing for Gene Therapyover 5 years ago
Minimizing Contamination During Biopharma R&DNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
